FRI06 - Industry Sponsored Session | Advances in targeted therapy for CLL and AML: Efficacy and practical management of BCL-2 inhibitors Presented by AbbVie

Description

This session will provide advanced practitioners an understanding of venetoclax safety and efficacy data. In addition, the practical management of venetoclax therapy in patients with CLL and AML will be discussed.

Speaker(s):

• Krista Tucker, MS, APRN-BC, AOCN, Tufts Medical Center